Chofu, Japan

Mineharu Hiiragi


Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Chofu, JP (1979)
  • Tokyo, JP (1985)

Company Filing History:


Years Active: 1979-1985

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Mineharu Hiiragi

Introduction

Mineharu Hiiragi is a notable inventor based in Chofu, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds with therapeutic applications. With a total of two patents to his name, Hiiragi's work focuses on innovative solutions that address medical needs.

Latest Patents

Hiiragi's latest patents include the development of N-Phthalidyl-5-fluorouracils and 2-Oxo-phenylbutanoic acid derivatives. These derivatives are characterized by their general formula, wherein X can be amino, hydroxy, or lower alkoxy. They exhibit anti-inflammatory activity and low toxicity, making them valuable in therapeutic contexts. Additionally, his patents detail methods for producing these derivatives, pharmaceutical compositions containing therapeutically effective amounts of the compounds, and their uses in therapeutics.

Career Highlights

Hiiragi is associated with Grelan Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing the understanding and application of new therapeutic compounds.

Collaborations

Hiiragi has collaborated with notable colleagues such as Kazuo Kigasawa and Haruhide Ishimaru. Their combined expertise has contributed to the successful development of innovative pharmaceutical solutions.

Conclusion

Mineharu Hiiragi's contributions to the field of pharmaceuticals through his patents and collaborations highlight his role as a significant inventor. His work continues to impact therapeutic advancements, showcasing the importance of innovation in medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…